Skip to main content
Top
Published in: Journal of General Internal Medicine 4/2007

01-04-2007 | Case Reports/Clinical Vignettes

Hyperammonemic Coma—Barking Up the Wrong Tree

Authors: Doron Rimar, MD, Eti Kruzel-Davila, MD, Guy Dori, MD, PhD, Elzbieta Baron, MD, Haim Bitterman, MD

Published in: Journal of General Internal Medicine | Issue 4/2007

Login to get access

Abstract

Hepatic encephalopathy and myxedema coma share clinical features: coma, ascites, anemia, impaired liver functions, and a “metabolic” electroencephalogram (EEG). Hyperammonemia, a hallmark of hepatic encephalopathy, has also been described in hypothyroidism. Differentiation between the 2 conditions, recognition of their possible coexistence, and the consequent therapeutic implications are of utmost importance. We describe a case of an 82-year-old woman with a history of mild chronic liver disease who presented with hyperammonemic coma unresponsive to conventional therapy. Further investigation disclosed severe hypothyroidism. Thyroid hormone replacement resulted in gain of consciousness and normalization of hyperammonemia. In patients with an elevated ammonia level, altered mental status, and liver disease, who do not have a clear inciting event for liver disease decompensation, overwhelming evidence of hepatic decompensation, or who do not respond to appropriate therapy for hepatic encephalopathy, hypothyroidism should be considered and evaluated.
Literature
1.
go back to reference Wall CR. Myxedema coma: diagnosis and treatment. Am Fam Phys. 2000;62(11):2485–90. Wall CR. Myxedema coma: diagnosis and treatment. Am Fam Phys. 2000;62(11):2485–90.
2.
go back to reference Bickford RG, Butt HR. Hepatic coma: the electroencephalographic pattern. J Clin Invest. 1955;34:790–99.PubMedCrossRef Bickford RG, Butt HR. Hepatic coma: the electroencephalographic pattern. J Clin Invest. 1955;34:790–99.PubMedCrossRef
3.
go back to reference Karnaze DS, Bickford RG. Triphasic waves: a reassessment of their significance. Electroencephalogr Clin Neurophysiol. 1984;57(3):193–8.PubMedCrossRef Karnaze DS, Bickford RG. Triphasic waves: a reassessment of their significance. Electroencephalogr Clin Neurophysiol. 1984;57(3):193–8.PubMedCrossRef
4.
go back to reference River Y, Zelig O. Triphasic waves in myxedema coma. Clin Electroencephalogr. 1993;24(3):146–50.PubMed River Y, Zelig O. Triphasic waves in myxedema coma. Clin Electroencephalogr. 1993;24(3):146–50.PubMed
5.
go back to reference Cindoruk M, Yetkin I, Karakan T, et al. The prevalence of autoimmune hepatitis in hashimoto’s thyroiditis in a Turkish population. Acta Gastroenterol Belg. 2002;65(3):143–5.PubMed Cindoruk M, Yetkin I, Karakan T, et al. The prevalence of autoimmune hepatitis in hashimoto’s thyroiditis in a Turkish population. Acta Gastroenterol Belg. 2002;65(3):143–5.PubMed
6.
go back to reference Zeniya M. Thyroid disease in autoimmune liver diseases. Nippon Rinsho. 1999;57(8):882–7. Zeniya M. Thyroid disease in autoimmune liver diseases. Nippon Rinsho. 1999;57(8):882–7.
7.
go back to reference Antonelli A, Ferri C, Pampana A, et al. Thyroid disorders in chronic hepatitis C. Am J Med. 2004;117(1):10–3.PubMedCrossRef Antonelli A, Ferri C, Pampana A, et al. Thyroid disorders in chronic hepatitis C. Am J Med. 2004;117(1):10–3.PubMedCrossRef
8.
go back to reference Tajiri J, Shimada T, Naomi S, et al. Hepatic dysfunction in primary hypothyroidism. Endocrinol Jpn. 1984;31(1):83–91.PubMed Tajiri J, Shimada T, Naomi S, et al. Hepatic dysfunction in primary hypothyroidism. Endocrinol Jpn. 1984;31(1):83–91.PubMed
9.
go back to reference Marti J, Portoles M, Jimenez-Nacher I, et al. Effect of thyroid hormones on urea biosynthesis and related processes in rat liver. Endocrinology. 1988;123:2167–74.PubMed Marti J, Portoles M, Jimenez-Nacher I, et al. Effect of thyroid hormones on urea biosynthesis and related processes in rat liver. Endocrinology. 1988;123:2167–74.PubMed
10.
go back to reference Baker A, Kaplan M, Wolfe H. Central congestive fibrosis of the liver in myxedema ascites. Ann Intern Med. 1972;77(6):927–9.PubMed Baker A, Kaplan M, Wolfe H. Central congestive fibrosis of the liver in myxedema ascites. Ann Intern Med. 1972;77(6):927–9.PubMed
11.
go back to reference McCall M, Bourgeois JA. Valproic acid-induced hyperammonemia: a case report. J Clin Psychopharmacol. 2004;24(5):521–6.PubMedCrossRef McCall M, Bourgeois JA. Valproic acid-induced hyperammonemia: a case report. J Clin Psychopharmacol. 2004;24(5):521–6.PubMedCrossRef
12.
go back to reference Kim YA, Chung HC, Choi HJ, Rha SY, Seong JS, Jeung HC. Intermediate dose 5-fluorouracil-induced encephalopathy. Jpn J Clin Oncol. 2006;36(1):55–9.PubMedCrossRef Kim YA, Chung HC, Choi HJ, Rha SY, Seong JS, Jeung HC. Intermediate dose 5-fluorouracil-induced encephalopathy. Jpn J Clin Oncol. 2006;36(1):55–9.PubMedCrossRef
13.
go back to reference Cheang HK, Rangecroft L, Plant ND, Morris AA. Hyperammonaemia due to Klebsiella infection in a neuropathic bladder. Pediatr Nephrol. 1998;12(8):658–9.PubMedCrossRef Cheang HK, Rangecroft L, Plant ND, Morris AA. Hyperammonaemia due to Klebsiella infection in a neuropathic bladder. Pediatr Nephrol. 1998;12(8):658–9.PubMedCrossRef
14.
go back to reference Thobe N, Pilger P, Jones MP. Primary hypothyroidism masquerading as hepatic encephalopathy: case report and review of the literature. Postgrad Med J. 2000;76(897):424–6.PubMedCrossRef Thobe N, Pilger P, Jones MP. Primary hypothyroidism masquerading as hepatic encephalopathy: case report and review of the literature. Postgrad Med J. 2000;76(897):424–6.PubMedCrossRef
15.
go back to reference Hitoshi S, Terao Y, Sakuta M. Portal-systemic encephalopathy and hypothalamic hypothyroidism: effect of thyroid hormone on ammonia metabolism. Intern Med. 1993;32(8):655–8.PubMed Hitoshi S, Terao Y, Sakuta M. Portal-systemic encephalopathy and hypothalamic hypothyroidism: effect of thyroid hormone on ammonia metabolism. Intern Med. 1993;32(8):655–8.PubMed
16.
go back to reference Yamamoto T, Takeuchi K, Okuda C, et al. Symptomatic hypothyroidism in decompensated liver cirrhosis. J Clin Gastroenterol. 2001;33(2):172–3.PubMedCrossRef Yamamoto T, Takeuchi K, Okuda C, et al. Symptomatic hypothyroidism in decompensated liver cirrhosis. J Clin Gastroenterol. 2001;33(2):172–3.PubMedCrossRef
17.
go back to reference Hashiguchi H, Mera T, Hashimoto T, Tsuji S. A case of portal-systemic encephalopathy associated with Sheehan’s syndrome. Rinsho Shinkeigaku. 2000;40(2):131–4.PubMed Hashiguchi H, Mera T, Hashimoto T, Tsuji S. A case of portal-systemic encephalopathy associated with Sheehan’s syndrome. Rinsho Shinkeigaku. 2000;40(2):131–4.PubMed
18.
go back to reference De Nardo D, Franconi G, Sabino D. Hyperammonemia during hypothyroidism: an unusual biohumoral finding normalized by hormonal replacement treatment. Ann Ital Med Interna. 1999;14(3):196–201. De Nardo D, Franconi G, Sabino D. Hyperammonemia during hypothyroidism: an unusual biohumoral finding normalized by hormonal replacement treatment. Ann Ital Med Interna. 1999;14(3):196–201.
19.
go back to reference Grofte T, Wolthers T, Jensen DS, et al. Hepatic amino nitrogen conversion and organ N-contents in hypothyroidism, with thyroxine replacement, and in hyperthyroid rats. J Hepatol. 1997;26(2):409–16.PubMedCrossRef Grofte T, Wolthers T, Jensen DS, et al. Hepatic amino nitrogen conversion and organ N-contents in hypothyroidism, with thyroxine replacement, and in hyperthyroid rats. J Hepatol. 1997;26(2):409–16.PubMedCrossRef
20.
go back to reference Marchesini G, Fabbri A, Bianchi GP, et al. Hepatic conversion of amino nitrogen to urea nitrogen in hypothyroid patients and upon l-thyroxine therapy. Metabolism. 1993;42(10):1263–9.PubMedCrossRef Marchesini G, Fabbri A, Bianchi GP, et al. Hepatic conversion of amino nitrogen to urea nitrogen in hypothyroid patients and upon l-thyroxine therapy. Metabolism. 1993;42(10):1263–9.PubMedCrossRef
21.
go back to reference Ingbar SH. Effects of thyroid hormones on metabolic processes. In: Williams Textbook of Endocrinology, 7th Edition. Philadelphia: WB Saunders, 1985:738. Ingbar SH. Effects of thyroid hormones on metabolic processes. In: Williams Textbook of Endocrinology, 7th Edition. Philadelphia: WB Saunders, 1985:738.
22.
go back to reference Burstein PJ, Draznin B, Johnson CJ, et al. The effect of hypothyroidism on growth, serum growth hormone, the growth hormone-dependent somatomedin, insulin-like growth factor, and its carrier protein in rats. Endocrinology. 1979;104(4):1107–11.PubMedCrossRef Burstein PJ, Draznin B, Johnson CJ, et al. The effect of hypothyroidism on growth, serum growth hormone, the growth hormone-dependent somatomedin, insulin-like growth factor, and its carrier protein in rats. Endocrinology. 1979;104(4):1107–11.PubMedCrossRef
Metadata
Title
Hyperammonemic Coma—Barking Up the Wrong Tree
Authors
Doron Rimar, MD
Eti Kruzel-Davila, MD
Guy Dori, MD, PhD
Elzbieta Baron, MD
Haim Bitterman, MD
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 4/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0131-6

Other articles of this Issue 4/2007

Journal of General Internal Medicine 4/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.